Estate Planning for Physicians: Protecting the Practice Before the Crisis

A physician's death mid-practice is not a simple event. Unlike salaried employees who can be replaced, physicians are bound by partnership agreements, medical licenses, patient relationships, and regulatory obligations that cannot be transferred through probate alone. A cardiologist in a three-physician practice dies unexpectedly; the partnership faces chaos within hours: unfinished patient cases, suspended admitting privileges, partnership debt obligations, controlled substance registrations, and a practice valuation dispute that could consume the estate for months.

This guide walks through the estate planning and succession mechanics that matter most to practicing physicians, medical group owners, and the professionals who advise them. The goal is protection: ensuring that when death occurs, the medical practice transitions, the estate is fairly valued, the surviving partners can afford the buyout, and patient care continues without disruption.

Medical Practice Valuation and Partnership Interest

A medical practice is valued entirely differently than a corporate job or a salary. A physician in a group is often a partner or shareholder with an ownership stake in the business itself. That stake has significant value, but calculating it requires understanding how medical practices are appraised.

Healthcare Practice Valuation Methods

Medical practices are typically valued using a multiple of EBITDA: earnings before interest, taxes, depreciation, and amortization. This is the standard metric across healthcare valuation, and practices commonly command multiples between 1x and 3x EBITDA depending on specialty, patient base, and reimbursement contracts.

A primary care practice with stable Medicare and insurance billing, strong patient retention, and established referral relationships might be valued at 2.5x EBITDA. A surgical specialty practice with higher reimbursement but more volatile patient scheduling might be valued at 1.5x EBITDA. A specialized imaging or procedural center with long-term contracts might command 3x or higher.

The EBITDA multiple reflects the stability and transferability of the practice's revenue stream. The higher the reimbursement certainty and the lower the physician-dependency, the higher the multiple.

Patient Roster and Goodwill Valuation

Patient relationships often represent 50 to 70 percent of a medical practice's total value. Medical practices are built on continuity of care and trust. A patient who has seen the same cardiologist for 15 years is more likely to continue under the surviving physicians than a patient with a new internist who just joined the group.

This patient relationship value is called goodwill, and it is a distinct asset separate from physical assets like equipment, furnishings, and real estate. When a practice is valued at 2x EBITDA, much of that multiple is goodwill, not tangible assets. This matters for the estate because it means the deceased physician's partnership interest includes a substantial intangible asset that must be paid for by the surviving partners.

Without goodwill valuation, the estate might believe the practice is worth only the net value of equipment and leasehold improvements, while surviving partners are counting on a much higher value based on the patient base.

Buy-Sell Agreement Formula Pricing

Most medical partnerships specify a valuation formula in their buy-sell agreement rather than requiring an independent appraisal at death. Common formulas include:

• A specified multiple of EBITDA calculated annually
• Book value plus goodwill calculated annually
• A fixed price adjusted annually or at partnership agreement renewal
• An appraisal formula with specified adjustor (e.g., recent appraisal adjusted for revenue growth)

Formula pricing has advantages: it avoids valuation disputes at death, clarifies expectations, and enables insurance funding because the partnership knows the insurance need in advance. However, formulas can undervalue or overvalue a practice depending on market conditions and the formula's age. A formula set 10 years ago may no longer reflect the practice's true value.

Physicians should review partnership valuation formulas every 3 to 5 years and ensure the formula aligns with current market conditions and the group's financial performance.

Assets vs. Equity Value

Some partnerships value assets separately: equipment, furniture, real estate, goodwill, and accounts receivable are each appraised, and the deceased physician's interest equals a percentage of net asset value. Other partnerships use an equity method: the total net asset value of the partnership is divided equally among partners, or divided according to ownership percentages specified in the agreement.

Medical equipment is often financed over time and is depreciated on tax returns, so net equity in equipment may be modest despite the practice's substantial revenue-generating capacity. A $2 million diagnostic imaging center might have net equipment value of only $400,000 if the equipment was financed over 7 years and is currently 5 years through its depreciation schedule. But the equipment generates $1.5 million in annual revenue, so the practice value (5x EBITDA, for instance) would be far higher than the net equipment value.

This distinction matters because if the buy-sell agreement values the practice on an asset-by-asset basis without accounting for goodwill, the estate might receive far less than the actual value the surviving partners derive from the deceased physician's patient relationships and reputation.

Key-Person Insurance and Buyout Mechanics

The only reliable way to fund a partnership buyout at death is through key-person insurance on the deceased physician's life. Without it, the surviving partners must either deplicate their cash reserves, take out bank loans, or negotiate seller financing with the estate, all of which create strain and potential disputes.

Key-Person Insurance: Definition and Purpose

Key-person insurance is a life insurance policy on a physician's life, typically owned by the partnership or group. When the physician dies, the insurance company pays the death benefit directly to the partnership. That money is used to purchase the deceased physician's interest from the estate at the price specified in the partnership agreement.

The key advantage is liquidity: the partnership can immediately pay the estate without waiting for bank approval, liquidating assets, or forcing surviving physicians to personally guarantee a loan.

Key-person insurance is distinct from personal life insurance that a physician might own for family protection. Key-person insurance is an asset of the partnership and is explicitly named as the funding mechanism for the buy-sell agreement.

Insurance Funding Buy-Sell Agreement

The structure works like this:

1. The partnership buys a life insurance policy on each physician's life
2. The partnership pays the premiums (these are not tax-deductible for the partnership, but the death benefit is received tax-free)
3. When a physician dies, the insurance pays the death benefit to the partnership
4. The partnership uses those proceeds to buy the deceased physician's partnership interest from the estate, per the buy-sell agreement
5. The surviving partners own the entire practice; the estate receives cash equivalent to the deceased physician's share

This mechanism avoids forced asset sales, keeps the practice operational, and ensures the estate receives fair value in liquid form rather than waiting months or years for the partnership to generate the cash.

Adequate Insurance Calculation

The standard rule is: insurance coverage = practice value divided by number of partners. If a three-physician practice is valued at $3 million, the partnership needs $1 million in life insurance on each physician. If the practice is valued at $5 million with four partners, each physician should have $1.25 million in coverage.

This formula assumes equal ownership. If ownership percentages differ, the formula adjusts: if one physician owns 40 percent of a $3 million practice and another owns 30 percent, the first physician should be insured for $1.2 million and the second for $900,000.

Many partnerships under-insure by accident: they buy insurance based on outdated practice valuations, or they fail to increase coverage as the practice grows. If the practice value doubles but insurance coverage stays at the original level, the partnership cannot afford the buyout if a physician dies.

Taxation of Insurance Proceeds

Life insurance death benefits are received tax-free by the partnership under IRC Section 101(a)(1). This is a major advantage: $1 million in death benefits is $1 million in cash, not $650,000 after federal taxes.

However, when the partnership uses those proceeds to buy the deceased physician's partnership interest, the partnership receives no tax deduction for the purchase. The purchase is a transfer of ownership, not an expense. The inside build-up of cash in the partnership is not taxed, but the surviving partners' basis in their interest does not increase.

This has implications for eventual sale of the practice: if the practice is later sold to an outside party, the surviving partners' basis does not include the amount paid to the deceased physician's estate, so their capital gain may be higher than expected.

Physicians should consult their accountant and attorney about the tax implications of their specific partnership structure before assuming that insurance proceeds solve all funding issues.

Disability-to-Death Provisions and Contingency Planning

Some partnership agreements include mechanisms for buyout if a physician becomes permanently disabled. These provisions interact with disability insurance and create complex scenarios at death.

Disability Buyout Trigger and Valuation

A disability buyout is triggered when a physician becomes unable to practice medicine due to illness or injury. The partnership buys out the disabled physician's interest, usually at a discount from full value: perhaps 50 to 80 percent of the standard partnership price, reflecting the reality that the disabled physician may not recover and will not generate revenue for the partnership going forward.

A disability buyout allows the disabled physician to exit the partnership while retaining some cash value, and it allows the remaining partners to reorganize without the disabled partner's share of debt or obligations. The disabled physician typically must cease all practice involvement.

Disability Insurance and Long-Term Care Linkage

Most physicians carry disability insurance provided by the group or purchased individually. This insurance typically covers 60 to 70 percent of income if the physician becomes unable to work, with benefits lasting 2 to 5 years depending on the policy.

Some disability policies include a rider that converts the disability benefit to a death benefit if the insured remains disabled after the benefit period expires. For instance, if a physician becomes disabled at age 50 and the disability policy pays benefits for 5 years but the physician never recovers, the policy might convert to a $1 million death benefit payable at age 65 or upon actual death.

The coordination between disability insurance, disability buyout provisions, and life insurance buyout provisions must be carefully structured so that benefits are clearly allocated and there are no gaps or double-coverage.

Death During Disability Waiting Period

A tricky scenario: a physician becomes disabled and files a disability insurance claim; the insurer is reviewing the claim, and the physician dies before the claim is approved or the benefit period begins. The partnership may believe that the disability buyout provision applies and the buyout is discounted. The estate may argue that the physician never was formally deemed "permanently disabled" and full partnership value should apply.

Similarly, if a physician is on disability and the disability insurance benefit is being paid, and then the physician dies, the partnership must clarify whether the death buy-sell agreement takes precedence or the disability agreement carries through.

These scenarios require crystal-clear language in the partnership agreement about the order of precedence: does death always trigger the full buyout value, or does disability status affect the buyout price even if death occurs?

Partnership Agreement Structure and Succession

The partnership agreement itself is the master document that controls everything: buyout triggers, valuation, timing, and the mechanism by which the deceased physician's interest passes.

Mandatory vs. Optional Buy-Sell

A mandatory buy-sell agreement requires the estate to sell the partnership interest and requires the surviving partners to buy it. This prevents the estate from retaining a partnership stake or selling the interest to a third party.

An optional buy-sell allows the surviving partners to elect whether to buy the deceased partner's interest. If they decline, the estate can retain the interest (and continue to receive partnership distributions) or sell to a third party.

Mandatory buy-sell is far more favorable to the surviving partners: it prevents an estate from becoming an unwilling partner, removes the possibility of a third party entering the partnership, and ensures clean separation. From the estate's perspective, it guarantees liquidity.

Optional buy-sell gives flexibility but creates risk: if the partnership is declining in value or unprofitable, the surviving partners may refuse to buy, leaving the estate with an illiquid ownership stake in a business it cannot control.

Physicians should strongly prefer mandatory buy-sell and should ensure that partnership agreements clearly state that the estate must sell and surviving partners must buy, with timing and payment terms specified.

Installment Payout and Seller Financing

If the insurance proceeds are insufficient to cover the full buyout price, the partnership agreement may allow for installment payout: the partnership pays the estate over 3 to 5 years with a promissory note.

Seller financing (the estate financing the sale to the surviving partners) is common in medical practice succession because the surviving partners often cannot immediately pay the full buyout amount in cash, and the partnership cannot take on additional debt from external lenders.

The promissory note should specify:

• Total amount and principal outstanding
• Interest rate (usually at or near market rates to avoid tax complications)
• Payment schedule (quarterly, monthly, or annual payments)
• Security terms (personal guarantees from surviving partners, lien on partnership assets, or unsecured)
• Default provisions and remedies
• Acceleration clause if surviving partners die or the practice is sold

Without detailed promissory note terms, disputes often arise: surviving partners believe they can defer payment if the practice has a bad year; the estate demands full payment on schedule; conflict escalates to litigation.

Cross-Purchase vs. Redemption Structure

There are two structural approaches to the buy-sell mechanism:

Cross-purchase: Each surviving partner personally buys a proportional share of the deceased partner's interest directly from the estate. If two physicians remain, they each buy 50 percent of the deceased partner's stake.

Redemption: The partnership itself buys the deceased partner's interest and retires it. The surviving partners' ownership percentages increase proportionally, but they do not directly buy the deceased partner's stake.

Cross-purchase is generally more favorable to surviving partners for tax reasons: surviving partners receive a stepped-up basis in the interest they purchase, reflecting the full purchase price paid at death. When the practice is later sold, capital gains are calculated on the stepped-up basis, potentially reducing overall tax burden.

Redemption is simpler administratively: the partnership makes one purchase from the estate rather than each surviving partner making individual purchases. However, tax treatment can be less favorable depending on partnership structure and state law.

Physicians and their advisors should model both structures and determine which is preferable given the partnership's specific tax situation.

Patient Continuity and Non-Compete Issues

A physician's death leaves patients without their treating physician. The partnership faces immediate questions: who will assume the patient care load, what happens to patients who prefer another provider, and what if the deceased physician's estate tries to redirect patients to a competing practice?

Patient Transition and Non-Compete Coordination

When a physician dies, the surviving physicians typically assume the deceased's patient load. Office staff contact patients to notify them of the transition and to encourage continuity with the surviving physicians. Most patients continue with the practice out of convenience and established relationships with staff, though some will seek alternative providers.

Partnership agreements almost always include non-compete clauses that restrict the deceased physician's estate from competing or soliciting patients. A typical non-compete might state: "Upon death of a physician, the estate shall not establish, own, or work in a competing medical practice within 25 miles for a period of 3 years."

This protects the surviving partners' ability to retain patients and prevents the estate (if it retains partnership proceeds or owns a competing practice) from poaching patients who were originally the deceased physician's.

Non-Compete Enforceability and Physician Mobility

Non-competes in medical partnerships are scrutinized by courts for reasonableness in three dimensions: geographic scope, duration, and whether they protect a legitimate business interest (patient relationships, goodwill, confidential information).

A non-compete preventing competition within 25 miles for 3 years is generally enforceable in most states if the practice is in a specific geographic market. A non-compete preventing any medical practice anywhere in the United States for 10 years would likely be struck down as overly broad.

The enforceability of non-competes varies significantly by state. Some states (like California) disfavor non-competes entirely and rarely enforce them. Others (like Texas and Florida) enforce reasonable non-competes routinely. Physicians in states with restrictive non-compete law should understand that their partnership's non-compete may not be enforceable, which limits the partnership's ability to prevent competition by the deceased physician's estate or heirs.

Restrictive Covenant and Physician Relocation

If the deceased physician's estate retains proceeds from the buyout and attempts to establish a competing medical practice in the same geographic market, a valid non-compete restricts patient solicitation and referral relationships. Surviving physicians can seek injunctive relief (court order preventing competition) and damages for lost revenue.

However, the analysis depends on state law, the specificity of the non-compete language, and whether the deceased physician's estate is directly competing or merely restricting the mobility of an heir who is also a physician.

In some states, a physician heir cannot be bound by the deceased parent's non-compete clause; only the deceased physician's own mobility is restricted. The estate cannot prevent the heir from practicing, but it may be liable for lost revenue if the heir solicits the deceased physician's patients in violation of non-compete terms.

These scenarios require careful consultation with healthcare attorneys in the relevant state.

Medical Records and Licensure

Physician death creates regulatory and compliance obligations that extend well beyond the partnership agreement.

Medical Record Transfer and Patient Consent

Medical records are the property of the medical practice or, in some jurisdictions, held in trust for the patient. The estate cannot keep the deceased physician's records; they must transfer to the surviving physicians or to a medical records storage vendor as required by state law and HIPAA.

The surviving physicians assume the legal obligation to maintain records in compliance with state regulations (typically 5 to 10 years from the date of last visit, depending on state law and specialty). This includes secure storage, access controls, and response to patient records requests.

Patient consent is generally not required to transfer records among physicians in the same group or when a group continues operations after a physician's death. However, some states require notice to patients and an opportunity to retrieve records; a few states require explicit written consent.

The partnership agreement should address medical record responsibility clearly: who is responsible for storage costs, who responds to records requests, and how long records are retained after the practice is sold or closed.

Physician License and Peer Review Liability

When a physician dies, the state medical board places the license on inactive status. The estate cannot practice medicine or bill using the deceased physician's license.

However, peer review investigations and malpractice claims may survive the physician's death. If a patient claims that the deceased physician's care fell below the standard of care and caused injury, the claim can proceed against the physician's estate. The partnership's malpractice insurance typically covers prior acts by deceased physicians, but the estate may be named as a defendant and could incur defense costs.

Peer review is a special concern: a hospital or surgical center may open a peer review investigation after learning of a complication or poor outcome from a procedure performed by a deceased physician. The investigation proceeds; the estate may need to respond to discovery requests, and the deceased physician cannot testify to explain the treatment decisions.

Malpractice tail coverage (discussed below) is designed to protect against these post-death claims.

DEA Registration and Controlled Substance Destruction

If the physician was authorized to prescribe controlled substances (DEA Schedule II-V drugs), the DEA registration must be surrendered to the DEA after the physician's death.

Any controlled substances in the office inventory must be disposed of according to DEA rules: typically, a DEA Form 106 (Notice of Theft or Loss of Controlled Substances) and Form 107 (Registrant's Inventory of Controlled Substances) are filed, and the substances are destroyed by a licensed DEA-authorized destruction vendor or the DEA itself.

The partnership cannot reassign the deceased physician's DEA registration to another physician. A surviving physician with their own DEA registration can simply continue prescribing, but the deceased physician's registration and drug stock must be formally surrendered and destroyed.

Failure to properly surrender DEA registration and destroy controlled substances can result in regulatory penalties and criminal charges. This is a critical compliance item that must be handled in the first days after the physician's death, often before the estate administration is fully underway.

Group Practice and Employment Issues

Not all physicians are partners. Many are employed by medical groups, hospitals, or larger physician organizations as W-2 employees. Their estate planning and succession mechanics are fundamentally different.

Employment vs. Partnership Distinction

An employed physician has no ownership interest in the group. Death creates no succession issue and no buyout obligation. The group continues operations, assumes the physician's patient load, and the estate receives no partnership proceeds.

However, the employment agreement may include death benefits: a lump sum payment to the estate, continuation of health insurance for a period, or other benefits. These are contractual, not proprietary rights, and they pass outside the estate through the employment contract terms.

Employed physicians should ensure that their employment agreement clearly specifies death benefits, insurance continuation, and what happens to accrued bonus or deferred compensation. Without these provisions, the estate may receive nothing beyond standard payroll benefits.

Shareholder vs. Partner Status

If the group is organized as a corporation or LLC, a physician may be a shareholder or member rather than a partner. Shareholder status means ownership of a defined percentage of the entity, which may be freely transferable or subject to restrictions in the shareholder/operating agreement.

A buy-sell agreement may require the group to buy the deceased physician's shares at a specified price, or it may allow the estate to retain or sell the shares. If shares are freely transferable, the estate might be able to sell to another physician or investor; if they are restricted, the group may have a right of first refusal or mandatory redemption.

The distinction between partnership, shareholder, and employee status has major implications for estate planning. A physician who owns 10 percent of an LLC valued at $10 million has a $1 million asset that must be addressed in the estate plan. An employed physician has no equity asset and no partnership buyout.

Retirement Plans and Deferred Compensation

Employed physicians often participate in group 401(k) plans, deferred compensation agreements, or pension plans. These benefits are separate from partnership equity and pass to named beneficiaries outside the estate, not subject to probate.

If a physician has both partnership equity and a 401(k) or deferred compensation arrangement, the estate plan must address both assets separately. The partnership interest may be subject to mandatory buyout and DEA/licensing issues; the retirement benefits are straightforward transfers to beneficiaries.

Coordination is critical: the estate should not plan to use 401(k) proceeds to cover the buyout of partnership interest if the 401(k) is already designated for a spouse or children, unless those beneficiaries have agreed to redirect the funds.

Succession Planning and Associate Transition

Many medical groups employ associate physicians with the expectation that successful associates will eventually buy into the partnership or ownership structure. A senior physician's death can disrupt this succession pipeline.

Associate Transition to Partnership

An associate physician typically works for 3 to 7 years before being offered partnership or shareholder status. The transition is earned through performance, demonstrated commitment, and financial capacity.

If a senior physician in the group dies, the associate's pathway to partnership may be accelerated (the senior physician's share becomes available for buyout by the associate), remain unchanged, or be cancelled entirely if the deceased physician's death creates financial stress on the group or if the group decides not to expand ownership.

The employment or associate agreement should clearly address what happens to the associate's buy-in opportunity if a senior partner dies. Ambiguity creates conflict: the associate believes the death accelerates their buy-in; the surviving partners believe it reduces partnership value and delays any buy-in.

Mentorship and Skill Transfer

This is a uniquely medical practice concern: patient relationships in medicine are built on trust and physician skill. When a patient has been treated by a specific cardiologist for years, the relationship is personal. The cardiologist has judgment, technique, and patient history that cannot be replicated by a new physician reading the chart.

If the cardiologist dies, surviving physicians can assume patient care and most patients will continue, but there will be disruption and some patient loss. A younger associate stepping into the deceased's role faces the additional challenge of lacking the established reputation and relationships.

The succession plan should anticipate this: if a senior physician in the group dies, is there an associate or junior partner prepared to assume the senior physician's complex patients? Or do surviving senior physicians have to redistribute the patient load, creating stress and potentially losing patients to other practices?

Specialty and Sub-Specialty Considerations

The impact of physician death varies dramatically by specialty.

Surgical specialties are highly disrupted: elective procedures halt while patients seek alternative surgeons. A patient with a scheduled hip replacement must find another orthopedic surgeon, and the deceased surgeon's open cases may need to be assumed by the surviving surgeons, creating immediate surgical load.

Primary care transitions more smoothly: patients rely on their internist for routine care, but there is less technical disruption, and continuity is relatively straightforward.

Emergency medicine and hospitalist practice transitions most easily: these physicians do not have long-term patient relationships; coverage is typically shift-based and easily redistributed among surviving physicians.

A group losing a surgeon should plan for significant revenue disruption and potential patient loss; a group losing an emergency physician faces scheduling challenges but minimal loss of revenue or patients.

FAQ: Key Questions About Physician Estate Planning

Q: What happens to a medical practice if an owner-physician dies?

A: If the physician is in a partnership, the buy-sell agreement typically requires the estate to sell the practice interest to surviving partners. Key-person insurance on the physician's life provides funds for the buyout. The surviving partners maintain operations and assume patient care.

If there is no buy-sell agreement or insurance, the partnership may lack liquidity to purchase the deceased partner's interest. The estate may retain an ownership stake (becoming an unwilling partner), the partnership may struggle to continue, or the practice may be forced to liquidate.

Q: Do I need key-person insurance as a practicing physician?

A: Yes, if you are in a partnership or own an equity stake in a group. Key-person insurance funds the buyout of your interest at death and protects the practice from financial crisis when a partner dies. Without it, surviving partners may not be able to afford the buyout, leaving the estate with an illiquid ownership stake.

If you are an employed physician with no ownership stake, key-person insurance is less critical unless your employment agreement includes bonuses or deferred compensation that could be lost at your death.

Q: Can surviving partners buy my practice from my estate?

A: Yes, typically required by the buy-sell agreement. The purchase price is determined by the valuation formula specified in the agreement (commonly a multiple of EBITDA, book value plus goodwill, or an appraisal). Key-person insurance proceeds are used to fund the purchase, and any shortfall is typically paid through installment notes or seller financing.

Q: What happens to my patients if I die mid-practice?

A: Surviving physicians assume your patient care load and your medical records. Most patients continue with the practice for convenience and established relationships with staff. Some patients may seek alternative providers, particularly if they prefer a different physician or want to relocate.

Non-compete clauses in the partnership agreement may restrict your estate from soliciting patients or operating a competing practice in the same geographic area for a specified period. This protects the surviving partners' ability to retain revenue from your patient relationships.

Q: Who is responsible for my DEA registration and controlled substance inventory if I die?

A: The DEA registration must be surrendered to the DEA within a specified period. Controlled substance inventory must be destroyed by a DEA-authorized vendor according to regulatory rules. The partnership typically handles this within the first few days after death to avoid regulatory violations.

Q: What happens to my medical malpractice liability after I die?

A: The partnership's malpractice insurance typically covers prior acts by deceased physicians, including incidents that occurred during the physician's practice but are claimed after death. Tail coverage (extended reporting period) protects against late-reported claims. The estate may be named as a defendant, but the insurance policy should cover defense costs and settlements.

Conclusion: Protecting the Practice and the Estate

Physician death mid-practice creates cascading complications: patient care disruption, regulatory compliance (DEA, licenses, medical records), partnership disputes over valuation and buyout, and estate liquidity challenges.

The defense is a well-structured plan that includes:

• A clear, current buy-sell agreement with defined valuation and mandatory buyout mechanics
• Key-person life insurance on each partner, reviewed annually and adjusted as practice value changes
• Partnership terms for installment payout and seller financing if insurance is insufficient
• Disability-to-death provisions coordinated with disability insurance
• Non-compete and patient transition procedures
• Clear assignment of responsibility for medical records, DEA registration, and controlled substance inventory
• Coordination with personal estate planning to ensure partnership interest is addressed, named beneficiaries are specified, and estate taxes are anticipated

Without this structure, the surviving partners are scrambling to fund a buyout while managing patient care disruption, and the estate is holding an illiquid partnership interest with limited options for liquidity or exit.

Afterpath helps medical groups manage the administrative timeline when a physician passes: tracking insurance premium payments to ensure coverage is adequate, flagging non-compete obligations and patient transition schedules, monitoring medical record transfer compliance, and coordinating with estate administration to ensure buyout mechanisms are triggered on schedule. The result is faster, cleaner practice succession and better outcomes for the estate, the surviving partners, and the patients depending on continuity of care.

---

Internal Links: professional-practice-valuation-estate.md, buy-sell-agreement-enforcement.md, partnership-succession-planning-nc.md

Cross-Links: Article 3 (Law Firm Partner Estates), Article 8 (Construction Company), Article 1 (Executor Liability)

Consumer Bridge: physician-succession-planning-guide.md, medical-practice-ownership-transfer.md

CTA: Afterpath manages medical practice succession timelines, tracks insurance premium payments, flags non-compete obligations, and monitors patient continuity and medical record transfer requirements.

AEO Citation Block: Medical practice valued as 1-3x EBITDA; patient relationships represent significant goodwill. Key-person insurance on physician funds buy-sell agreement buyout. Buy-sell agreement determines whether estate must sell or can retain interest. Non-compete clauses restrict competing practice. Disability insurance often includes conversion to death benefit. Partnership agreement specifies buyout mechanism (cross-purchase vs. redemption) and installment options.